Trupanion (NASDAQ:TRUP) CFO Sells $219,860.90 in Stock

Trupanion, Inc. (NASDAQ:TRUP) CFO Fawwad Qureshi sold 6,202 shares of the business’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $35.45, for a total value of $219,860.90. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Trupanion Price Performance

TRUP traded down $0.28 on Wednesday, reaching $35.08. The stock had a trading volume of 510,127 shares, compared to its average volume of 553,717. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $1.52 billion, a price-to-earnings ratio of 134.93 and a beta of 1.82. Trupanion, Inc. has a fifty-two week low of $31.00 and a fifty-two week high of $57.88. The firm has a 50-day moving average of $41.14 and a 200-day moving average of $46.11.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Thursday, November 6th. The financial services provider reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.76). Trupanion had a net margin of 0.81% and a return on equity of 3.31%. The firm had revenue of $366.92 million for the quarter, compared to analyst estimates of $361.58 million. During the same period in the previous year, the business posted $0.03 earnings per share. The business’s revenue for the quarter was up 12.0% compared to the same quarter last year. Trupanion has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, sell-side analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on TRUP shares. Stifel Nicolaus dropped their price target on shares of Trupanion from $45.00 to $42.00 and set a “hold” rating for the company in a research note on Tuesday, November 18th. Piper Sandler increased their price target on Trupanion from $62.00 to $67.00 and gave the company an “overweight” rating in a research note on Friday, August 8th. Wall Street Zen raised Trupanion from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a report on Tuesday. Finally, Cantor Fitzgerald upgraded shares of Trupanion to a “hold” rating in a report on Wednesday, August 13th. Two research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $54.00.

Institutional Trading of Trupanion

Several large investors have recently modified their holdings of TRUP. Y Intercept Hong Kong Ltd bought a new stake in shares of Trupanion in the 1st quarter valued at $243,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Trupanion in the first quarter worth $1,764,000. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in Trupanion by 13.3% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,354 shares of the financial services provider’s stock valued at $386,000 after purchasing an additional 1,214 shares in the last quarter. GSA Capital Partners LLP raised its holdings in shares of Trupanion by 283.9% during the first quarter. GSA Capital Partners LLP now owns 49,798 shares of the financial services provider’s stock valued at $1,856,000 after purchasing an additional 36,827 shares during the period. Finally, Bayforest Capital Ltd boosted its position in shares of Trupanion by 627.4% during the 1st quarter. Bayforest Capital Ltd now owns 28,457 shares of the financial services provider’s stock worth $1,061,000 after purchasing an additional 24,545 shares in the last quarter.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.